HUAKANG(SH:605077) Zheng Quan Zhi Xing·2025-08-21 10:22Core Viewpoint - Zhejiang Huakang Pharmaceutical Co., Ltd. plans to distribute a cash dividend of 2 yuan (including tax) for every 10 shares, based on the total share capital registered on the equity distribution date [1][2]. Summary by Sections Profit Distribution and Capital Increase Plan - As of June 30, 2025, the company has a distributable profit of 1,174.4735 million yuan [1]. - The proposed cash dividend distribution is based on the total share capital as of the equity distribution registration date, which is 30,304.9751 million shares as of August 20, 2025 [1]. - The cash dividend represents 45.33% of the company's net profit attributable to shareholders, with no capital increase from reserves planned [1]. Decision-Making Process - The company held the 32nd meeting of the sixth board of directors and the 21st meeting of the sixth supervisory board on August 21, 2025, where the profit distribution proposal was approved [2]. - The supervisory board believes the profit distribution plan considers the company's operational and financial status and aligns with relevant regulations, supporting sustainable development without harming the interests of the company and investors [2]. Additional Notes - If there are changes in total share capital due to convertible bonds, share buybacks, or other factors before the equity distribution registration date, the per-share distribution ratio will remain unchanged, and the total distribution amount will be adjusted accordingly [2]. - The profit distribution proposal is subject to approval at the company's second extraordinary general meeting of shareholders in 2025 [2].